Question 1

Is it safe to drink alcohol on Wegovy?

Accepted Answer

Wegovy itself does not directly interact with alcohol, but GLP-1 medications lower your tolerance and amplify hangovers + nausea. Multiple-drink sessions also worsen dehydration risk, which is already elevated on a GLP-1. If you choose to drink, stick to 1-2 drinks with food and water on the side.

Question 2

Why is my weight loss slowing 6 months in?

Accepted Answer

A plateau around month 6-9 is normal — metabolic adaptation reduces the deficit your dose creates. Three checks: are you hitting protein (0.7-1.0 g/lb body weight)? Are you lifting weights ≥2×/week to preserve muscle? Is your dose at the prescribed target? If all three are yes, this may be your sustainable maintenance.

Question 3

Can I take collagen powder with Zepbound?

Accepted Answer

Yes, no known interaction. Collagen is a protein source — counts toward your daily protein target. Helpful during rapid weight loss for skin and joint support. Choose unflavored hydrolyzed collagen and mix into coffee or smoothies.

Question 4

Do I have to stay on Wegovy forever?

Accepted Answer

GLP-1 medications are designed as chronic therapy for obesity — similar to how blood-pressure medications are taken indefinitely. STEP-4 and SURMOUNT-4 trials show patients regain about two-thirds of lost weight within a year of discontinuation. If cost or side effects force stopping, a slow taper with continued lifestyle support helps preserve some loss.

Question 5

What if my insurance denies Wegovy?

Accepted Answer

Three paths: (1) appeal with documentation of BMI ≥30 (or ≥27 + comorbidity) and a prior lifestyle-intervention attempt — about 40% of denials reverse on appeal; (2) use the Novo WegovyCare savings card to drop cost to $499/mo; (3) switch to compounded semaglutide via a telehealth provider, $99-249/mo. Our /tools/insurance-coverage-checker shows what your plan typically covers.

Question 6

My BMI is 27 with PCOS — can I get Zepbound?

Accepted Answer

PCOS-related insulin resistance qualifies as a weight-related comorbidity under most prescriber criteria. FDA-approved use of Zepbound is BMI ≥30 OR BMI ≥27 with at least one weight-related condition. PCOS is increasingly treated as qualifying. Document your PCOS diagnosis, and ask your prescriber — they will adjudicate on a case-by-case basis.